AstraZeneca News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

08.12.22	AZN:Camizestrant Delayed Disease Progression In Advanced ER-Positive Breast Cancer In Phase II Trial (RTTNews)
08.12.22	AZN:Phase III Trial Of Capivasertib Combination Shows Improvement In PFS In Metastatic Breast Cancer (RTTNews)
07.12.22	AstraZeneca Reports Positive Survival In Phase 3 Trial Of ENHERTU In HER2 Metastatic Breast Cancer (RTTNews)
02.12.22	Accenture Buys Fiftyfive5 (RTTNews)
30.11.22	AstraZeneca Announces Sale Of West Chester Site In Ohio - Quick Facts (RTTNews)
29.11.22	AstraZeneca To Buy Neogene Therapeutics For Up To $320 Mln (RTTNews)
16.11.22	Compugen Reports Advancement Of AZD2936 Into Phase 2 By AstraZeneca; Triggers Milestone Payment (RTTNews)
14.11.22	AstraZeneca : Imfinzi Combination Recommended For Approval In EU For Advanced Biliary Tract Cancer (RTTNews)
14.11.22	AstraZeneca: CHMP Recommends Approval Of Lynparza In Combination With Abiraterone, Prednisone (RTTNews)
11.11.22	AstraZeneca: FDA OKs Imfinzi + Imjudo With Chemotherapy For Metastatic Non-small Cell Lung Cancer (RTTNews)
10.11.22	Viatris, Kindeva Announce U.S. Court's Invalidation Of AstraZeneca's Symbicort Patent (RTTNews)
10.11.22	AstraZeneca Turns To Profit In Q3; Lifts FY22 Earnings Growth View (RTTNews)
09.11.22	AstraZeneca : FDA Panel Recommends Approval Of Asthma Treatment PT027 In Adults But Not For Children (RTTNews)
04.11.22	AstraZeneca : EU Approves Beyfortus For Prevention Of RSV Lower Respiratory Tract Disease In Infants (RTTNews)
01.11.22	AstraZeneca's COVID-19 Vaccine Vaxzevria Granted Full Marketing Authorization In Europe (RTTNews)
27.10.22	AZN : Phase III Trial Results Show Ultomiris Reduced Risk Of Relapse In AQP4 Ab+ NMOSD By 98.6% (RTTNews)
26.10.22	AZN : Camizestrant Improves Progression-free Survival In Phase II Trial In Advanced Breast Cancer (RTTNews)
26.10.22	Biotech Stocks Facing FDA Decision In November 2022 (RTTNews)
26.10.22	AstraZeneca: Capivasertib Phase III Trial Meets Primary Goals (RTTNews)
25.10.22	AstraZeneca: Fasenra Trial In EoE Did Not Meet One Of Two Dual-primary Endpoints (RTTNews)
11.10.22	Illumina In Research Collaboration With AstraZeneca To Accelerate AI-based Drug Target Discovery (RTTNews)
06.10.22	HONEYWELL BEGINS PRODUCTION OF NEAR-ZERO GLOBAL-WARMING-POTENTIAL MEDICAL PROPELLANT (PR Newswire)
04.10.22	Roche's PATHWAY Anti-HER2 (4B5) Test Gets FDA Approval To Identify Patients Eligible For ENHERTU (RTTNews)
30.09.22	Biotech Stocks Facing FDA Decision In October 2022 (RTTNews)
27.09.22	AstraZeneca : Japan Approves Koselugo For Rare Genetic Disease In Paediatric Patients (RTTNews)
23.09.22	Ionis: AstraZeneca Decides Not To Advance ION449 Into Phase 3 Based On Pre-specified Criteria (RTTNews)
23.09.22	AstraZeneca Announces Approval For Ultomiris By The European Commission (RTTNews)
22.09.22	AstraZeneca Announces Approval Of Lynparza In China (RTTNews)
21.09.22	AstraZeneca: Tezspire Gets EU Approval To Treat Severe Asthma (RTTNews)
16.09.22	AstraZeneca's Evusheld Gets CHMP Recommendation For EU Approval To Treat COVID-19 (RTTNews)
16.09.22	AstraZeneca: CHMP Recommends Beyfortus For EU Approval - Quick Facts (RTTNews)
12.09.22	AZN: Enhertu Continues To Show Meaningful Tumor Response In Lung Cancer Across Phase II Trial (RTTNews)
09.09.22	AstraZeneca Says LYNPARZA Combination Shows Meaningful OS In Ovarian Cancer Across Phase III Trials (RTTNews)
07.09.22	Ionis Presents Positive Results From Phase 3 Study Of Eplontersen In Neuropathy Impairment (RTTNews)
05.09.22	AstraZeneca's Forxiga Approved In China For Treatment Of Chronic Kidney Disease (RTTNews)
05.09.22	AstraZeneca: FDA Approves Imfinzi Plus Chemotherapy To Treat Biliary Tract Cancer (RTTNews)
30.08.22	AstraZeneca's Evusheld Approved In Japan For Prevention And Treatment Of SARS-CoV-2 Infection (RTTNews)
30.08.22	AstraZeneca: DELIVER Data Extend Clinically Meaningful Benefits Of Farxiga (RTTNews)
25.08.22	AstraZeneca Reports Approval Of Tagrisso, Ultomiris & Lynparza In Japan (RTTNews)
16.08.22	AstraZeneca: FDA Grants Priority Review To SNDA For Lynparza With Abiraterone For MCRPC (RTTNews)
15.08.22	AstraZeneca: DESTINY-Breast02 Results Confirm Efficacy Seen In Previous Trials Of ENHERTU (RTTNews)
12.08.22	AZN : Enhertu Approved In U.S. As First HER2 Directed Therapy For HER2 Mutant Metastatic NSCLC (RTTNews)
06.08.22	AstraZeneca : FDA Approves Enhertu For HER2-low Metastatic Breast Cancer (RTTNews)
01.08.22	Innate Pharma: AstraZeneca To Discontinue INTERLINK-1 Monalizumab Combination Trial (RTTNews)
29.07.22	AstraZeneca Q2 Profit Down, Confirms FY22 Core EPS View, Lifts Revenue Growth Outlook (RTTNews)
25.07.22	AstraZeneca: CHMP Recommends Tezspire For Severe Asthma In EU (RTTNews)
25.07.22	AstraZeneca: Enhertu Gets Priority Review In The US (RTTNews)
25.07.22	AstraZeneca : Ultomiris Recommended For Approval In EU For Treatment Of Neuromuscular Disease (RTTNews)
19.07.22	AstraZeneca Reports Approval Of Enhertu In The EU (RTTNews)
06.07.22	Canada To Throw Out 13.6 Mln AstraZeneca Vaccine Doses (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	74.30	1.53 %	K V
Holcim	87.38	1.49 %	K V
Roche Hldg G	251.00	1.46 %	K V
Swiss Re	130.35	1.44 %	K V
UBS Group	27.07	1.35 %	K V
Swisscom	501.00	0.52 %	K V
Lonza Grp	532.40	0.26 %	K V
Nestle	74.08	0.14 %	K V
Sonova Hldg	295.60	0.00 %	K V
Geberit	512.20	-0.39 %	K V

mehr

13:27		AstraZeneca-Aktie dennoch fester: AstraZeneca und Daiichi Sankyo rudern bei EU-Zulassungsantrag für Lungenkrebsmittel zurück
23.12.24		AstraZeneca-Aktie höher: EU-Zulassung für Tagrisso gegen weitere Lungenkrebsform
18.12.24		Schwacher Handel in New York: NASDAQ 100 am Mittwochnachmittag schwächer
04.12.24		Zuversicht in New York: NASDAQ 100 zum Handelsstart freundlich
03.12.24		Starker Wochentag in New York: NASDAQ 100 steigt zum Handelsende
03.12.24		Starker Wochentag in New York: NASDAQ 100 am Nachmittag mit Kursplus
03.12.24		Schwacher Wochentag in New York: NASDAQ 100 fällt am Mittag zurück
03.12.24		NASDAQ-Handel NASDAQ 100 zum Handelsstart schwächer

13:27

AstraZeneca-Aktie dennoch fester: AstraZeneca und Daiichi Sankyo rudern bei EU-Zulassungsantrag für Lungenkrebsmittel zurück

23.12.24

AstraZeneca-Aktie höher: EU-Zulassung für Tagrisso gegen weitere Lungenkrebsform

18.12.24

Schwacher Handel in New York: NASDAQ 100 am Mittwochnachmittag schwächer

04.12.24

Zuversicht in New York: NASDAQ 100 zum Handelsstart freundlich

03.12.24

Starker Wochentag in New York: NASDAQ 100 steigt zum Handelsende

03.12.24

Starker Wochentag in New York: NASDAQ 100 am Nachmittag mit Kursplus